No DLTs so far and let’s hope that continues. The images shared clearly demonstrate efficacy. Could we stand a chance for accelerated approval?
I think what is special is also the Cu64-Cu67 pair for diagnostic and treatment. And of course while not an outcome of the trials, FDA and other BP may prefer our pair given the easy of developing them over other imaging and treatment regimes.
No DLTs so far and let’s hope that continues. The images shared...
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.35 |
Change
0.220(5.33%) |
Mkt cap ! $1.352B | |||
| Open | High | Low | Value | Volume |
| $4.10 | $4.35 | $4.05 | $7.494M | 1.770M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2555 | $4.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.35 | 5589 | 4 |
View Market Depth
| Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.25 |
Change
0.220 ( 3.26 %) |
||||
| Open | High | Low | Volume | ||
| $4.09 | $4.31 | $4.09 | 45313 | ||
| Last updated 15.58pm 24/05/2024 ? | |||||
| CU6 (ASX) Chart |